Task: Answer the multiple-choice question.
Query: Which compound exhibits a -27.972% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a CCOC(=O)c1ccc(NC(=O)N2CCN(C(=O)C3CCCO3)CC2)cc1
b Nc1nonc1C(=O)NCCNS(=O)(=O)c1ccc(Br)cc1
Answer: b. Nc1nonc1C(=O)NCCNS(=O)(=O)c1ccc(Br)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Nc1nonc1C(=O)NCCNS(=O)(=O)c1ccc(Br)cc1
Nc1nonc1C(=O)NCCNS(=O)(=O)c1ccc(Br)cc1
4-amino-N-[2-[(4-bromophenyl)sulfonylamino]ethyl]-1,2,5-oxadiazole-3-carboxamide